TWIST1 and renal cell carcinoma: The polyclonal loss of miR-210 in renal cell carcinoma cells increased tumor growth in a xenograft model, and while detailed cellular phenotype and gene expression studies were not performed, TWIST1 was suggested as a contributing miR-210 target (Yoshino et al., 2017b).